Justin Patrick Sells 828 Shares of Itron (NASDAQ:ITRI) Stock

Itron, Inc. (NASDAQ:ITRIGet Free Report) SVP Justin Patrick sold 828 shares of the firm’s stock in a transaction on Friday, February 20th. The stock was sold at an average price of $100.17, for a total value of $82,940.76. Following the completion of the transaction, the senior vice president directly owned 33,516 shares of the company’s stock, valued at approximately $3,357,297.72. This trade represents a 2.41% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Itron Stock Performance

Itron stock traded down $4.33 on Monday, hitting $95.21. The company’s stock had a trading volume of 2,762,408 shares, compared to its average volume of 824,922. Itron, Inc. has a one year low of $88.57 and a one year high of $142.00. The firm has a market cap of $4.28 billion, a P/E ratio of 14.63, a price-to-earnings-growth ratio of 0.86 and a beta of 1.48. The company has a quick ratio of 1.56, a current ratio of 1.80 and a debt-to-equity ratio of 0.45. The company has a fifty day moving average price of $97.72 and a 200-day moving average price of $109.93.

Itron (NASDAQ:ITRIGet Free Report) last released its quarterly earnings data on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 EPS for the quarter, topping analysts’ consensus estimates of $2.19 by $0.27. The company had revenue of $571.66 million during the quarter, compared to the consensus estimate of $561.31 million. Itron had a net margin of 12.72% and a return on equity of 20.04%. The firm’s revenue for the quarter was down 6.7% compared to the same quarter last year. During the same period last year, the firm earned $1.35 EPS. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. On average, equities analysts anticipate that Itron, Inc. will post 5.33 earnings per share for the current year.

Analysts Set New Price Targets

ITRI has been the subject of a number of recent research reports. Oppenheimer increased their target price on Itron from $125.00 to $133.00 and gave the stock an “outperform” rating in a report on Wednesday, February 18th. Robert W. Baird set a $128.00 price objective on Itron and gave the stock an “outperform” rating in a research note on Wednesday, February 18th. Argus reissued a “hold” rating on shares of Itron in a report on Tuesday, November 4th. Zacks Research lowered shares of Itron from a “hold” rating to a “strong sell” rating in a report on Wednesday, January 28th. Finally, Johnson Rice upgraded shares of Itron from an “accumulate” rating to a “buy” rating and set a $130.00 target price for the company in a research report on Monday, January 5th. Eight investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $137.90.

Read Our Latest Research Report on ITRI

Trending Headlines about Itron

Here are the key news stories impacting Itron this week:

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in ITRI. EverSource Wealth Advisors LLC increased its position in Itron by 25.3% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock valued at $53,000 after acquiring an additional 81 shares in the last quarter. Amalgamated Bank grew its stake in shares of Itron by 0.7% during the third quarter. Amalgamated Bank now owns 13,060 shares of the scientific and technical instruments company’s stock valued at $1,627,000 after purchasing an additional 86 shares during the last quarter. PFG Investments LLC grew its stake in shares of Itron by 4.8% during the third quarter. PFG Investments LLC now owns 2,059 shares of the scientific and technical instruments company’s stock valued at $256,000 after purchasing an additional 94 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its position in Itron by 29.5% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 443 shares of the scientific and technical instruments company’s stock worth $41,000 after purchasing an additional 101 shares during the last quarter. Finally, Elevation Point Wealth Partners LLC lifted its holdings in Itron by 3.5% during the 2nd quarter. Elevation Point Wealth Partners LLC now owns 3,398 shares of the scientific and technical instruments company’s stock worth $447,000 after buying an additional 115 shares in the last quarter. Institutional investors and hedge funds own 96.19% of the company’s stock.

About Itron

(Get Free Report)

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.

Featured Stories

Insider Buying and Selling by Quarter for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.